Higher levels of supplemental oxygen ineffective in reducing risk of infection after liver transplantation
Poland: According to the latest research article published in BMC Medicine, in patients of liver transplantation (LT), a higher level of postoperative supplemental oxygen is ineffective in reducing infection risk.
Patients undergoing surgery are at future risk of infection, and it is a global public health issue. WHO guidelines and CDC recommendations for preventive strategy include the provision of an 80% fraction in all adults of inspired oxygen (FiO2) for 2–6 h postoperatively.
Immunosuppression necessitation in transplantation raises concerns about early postoperative infections. Previous research has reported the benefits of high FiO2 in patients with colorectal procedures. However, there is a lack of information for LT patients,
Considering this background, a team of researchers evaluated the efficacy and safety of high FiO2 to LT patients in an attempt to analyze infection prevention.
The researchers randomly assigned LT patients to either 28% or 80% FiO2 (fraction of inspired oxygen) for six postoperative hours. The main outcome was to check infections during the 30-day post-transplant period. Mortality, morbidity, pulmonary complications, hospital stay and ICU stay, the concentration of bilirubin, alanine and aspartate transaminase activity, and international normalized ratio (INR) were the secondary outcomes.
The study results could be summarised as follows:
- One hundred ninety-three patients were randomized to 28% ( 99 patients) and 80% ( 94 patients) FiO2.
- 34.0% (32 patients) assigned to 80% FiO2 had an infection.
- 23.2% (23 patients) assigned to 28% FiO2 had an infection.
- Patients randomized to 80% FiO2 had frequently developed severe complications, had longer ICU stay and had higher bilirubin concentration over the first five post-transplant days with a significant p-value.
- There was no difference reported between the two groups for other secondary outcomes.
Concluding further, postoperative hyperoxygenation, routine 80% postoperative FiO2 is not indicated for prophylaxis of infections in LT patients as it lacks efficaciousness.
The study's limitations include sample size, bias, and deviations from assigned groups.
Further reading:
Figiel, W et al. Postoperative Supplemental Oxygen in Liver Transplantation (PSOLT) does not reduce the rate of infections: results of a randomized controlled trial. BMC Med 21, 51 (2023). https://doi.org/10.1186/s12916-023-02741-w
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.